ArticleACS pharmacology & translational science2024

Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity".

Philipp Flury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.